Microenvironment-evoked cell lineage conversion: Shifting the focus from internal reprogramming to external forcing

Ageing Research Reviews

Volumn 12, Issue 1, 2013, Pages 29-38

  Lin, Ji ^a   Li, Mei Rong ^a   Ti, Dong Dong ^a   Chen, Mei Xia ^a   Hao, Hao Jie ^a   Zhao, Ya Li ^a   Fu, Xiao Bing ^a   Han, Wei Dong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cell lineage conversion; Microenvironment direction; Reprogramming

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; ASCORBIC ACID; AZACITIDINE; BONE MORPHOGENETIC PROTEIN 4; CYCLOPAMINE; DEXAMETHASONE; ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR 8; GROWTH FACTOR; HISTONE DEACETYLASE INHIBITOR; INDOLACTAM V; NICOTINAMIDE; NOGGIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT PROTEIN; RETINOIC ACID; ROSIGLITAZONE; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; TRICHOSTATIN A; UNINDEXED DRUG; WNT PROTEIN;

ANIMAL CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL TYPE; COCULTURE; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; ECTODERM; EMBRYO; EMBRYONIC STEM CELL; ENDODERM; ENZYME INHIBITION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MESODERM; MICROENVIRONMENT; MOTONEURON; MOUSE; MUSCLE CELL; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CELL LINEAGE; COCULTURE TECHNIQUES; CYTOLOGICAL TECHNIQUES; ENVIRONMENT; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS;

EID: 84867351023     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.04.002     Document Type: Review

References (118)

1. Allegrucci C., Wu Y.Z., Thurston A., Denning C.N., Priddle H., Mummery C.L., Ward-van Oostwaard D., Andrews P.W., Stojkovic M., Smith N., Parkin T., Jones M.E., Warren G., Yu L., Brena R.M., Plass C., Young L.E. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Human Molecular Genetics 2007, 16:1253-1268.
2. Arai A., Yamamoto K., Toyama J. Murine cardiac progenitor cells require visceral embryonic endoderm and primitive streak for terminal differentiation. Developmental Dynamics 1997, 210:344-353.
3. Blau H.M. How fixed is the differentiated state? Lessons from heterokaryons. Trends in Genetics 1989, 5:268-272.
4. Borowiak M., Maehr R., Chen S., Chen A.E., Tang W., Fox J.L., Schreiber S.L., Melton D.A. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 2009, 4:348-358.
5. Chambers S.M., Studer L. Cell fate plug and play: direct reprogramming and induced pluripotency. Cell 2011, 145:827-830.
6. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnology 2009, 27:275-280.
7. Chang M.Y., Kim D., Kim C.H., Kang H.C., Yang E., Moon J.I., Ko S., Park J., Park K.S., Lee K.A., Hwang D.Y., Chung Y., Lanza R., Kim K.S. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS ONE 2010, 5:e9838.
8. Chen S., Borowiak M., Fox J.L., Maehr R., Osafune K., Davidow L., Lam K., Peng L.F., Schreiber S.L., Rubin L.L., Melton D. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nature Chemical Biology 2009, 5:258-265.
9. Chen S., Takanashi S., Zhang Q., Xiong W., Zhu S., Peters E.C., Ding S., Schultz P.G. Reversine increases the plasticity of lineage-committed mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10482-10487.
10. Cobaleda C., Jochum W., Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007, 449:473-477.
11. Cohen D.E., Melton D. Turning straw into gold: directing cell fate for regenerative medicine. Nature Reviews Genetics 2011, 12:243-252.
12. Collins-Hooper H., Luke G., Cranfield M., Otto W.R., Ray S., Patel K. Efficient myogenic reprogramming of adult white fat stem cells and bone marrow stem cells by freshly isolated skeletal muscle fibers. Translational Research 2011, 158:334-343.
13. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology 2005, 23:1534-1541.
14. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., Moorman M.A., Kroon E., Carpenter M.K., Baetge E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology 2006, 24:1392-1401.
15. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
16. Ding S., Schultz P.G. A role for chemistry in stem cell biology. Nature Biotechnology 2004, 22:833-840.
17. Ding S., Wu T.Y., Brinker A., Peters E.C., Hur W., Gray N.S., Schultz P.G. Synthetic small molecules that control stem cell fate. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:7632-7637.
18. Dolmetsch R., Geschwind D.H. The human brain in a dish: the promise of iPSC-derived neurons. Cell 2011, 145:831-834.
19. Enver T., Pera M., Peterson C., Andrews P.W. Stem cell states, fates, and the rules of attraction. Cell Stem Cell 2009, 4:387-397.
20. Fomina-Yadlin D., Kubicek S., Walpita D., Dancik V., Hecksher-Sørensen J., Bittker J.A., Sharifnia T., Shamji A., Clemons P.A., Wagner B.K., Schreiber S.L. Small-molecule inducers of insulin expression in pancreatic alpha-cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15099-15104.
21. Frank-Kamenetsky M., Zhang X.M., Bottega S., Guicherit O., Wichterle H., Dudek H., Bumcrot D., Wang F.Y., Jones S., Shulok J., Rubin L.L., Porter J.A. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. Journal of Biology 2002, 1:10.
22. Galli R., Borello U., Gritti A., Minasi M.G., Bjornson C., Coletta M., Mora M., De Angelis M.G., Fiocco R., Cossu G., Vescovi A.L. Skeletal myogenic potential of human and mouse neural stem cells. Nature Neuroscience 2000, 3:986-991.
23. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462:587-594.
24. Guo G., Yang J., Nichols J., Hall J.S., Eyres I., Mansfield W., Smith A. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009, 136:1063-1069.
25. Gurdon J.B., Byrne J.A. The first half-century of nuclear transplantation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:8048-8052.
26. Gurdon J.B., Melton D.A. Nuclear reprogramming in cells. Science 2008, 322:1811-1815.
27. Hanna J., Markoulaki S., Schorderet P., Carey B.W., Beard C., Wernig M., Creyghton M.P., Steine E.J., Cassady J.P., Foreman R., Lengner C.J., Dausman J.A., Jaenisch R. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008, 133:250-264.
28. Hanna J., Markoulaki S., Mitalipova M., Cheng A.W., Cassady J.P., Staerk J., Carey B.W., Lengner C.J., Foreman R., Love J., Gao Q., Kim J., Jaenisch R. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 2009, 4:513-524.
29. Hayashi K., Lopes S.M., Tang F., Surani M.A. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 2008, 3:391-401.
30. Heddleston J.M., Li Z., McLendon R.E., Hjelmeland A.B., Rich J.N. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009, 8:3274-3284.
31. Hochedlinger K., Jaenisch R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 2002, 415:1035-1038.
32. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., Chen A.E., Melton D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nature Biotechnology 2008, 26:795-797.
33. Huangfu D., Osafune K., Maehr R., Guo W., Eijkelenboom A., Chen S., Muhlestein W., Melton D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology 2008, 26:1269-1275.
34. Idelson M., Alper R., Obolensky A., Ben-Shushan E., Hemo I., Yachimovich-Cohen N., Khaner H., Smith Y., Wiser O., Gropp M., Cohen M.A., Even-Ram S., Berman-Zaken Y., Matzrafi L., Rechavi G., Banin E., Reubinoff B. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009, 5:396-408.
35. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
36. Ikeda H., Osakada F., Watanabe K., Mizuseki K., Haraguchi T., Miyoshi H., Kamiya D., Honda Y., Sasai N., Yoshimura N., Takahashi M., Sasai Y. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11331-11336.
37. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes & Development 2001, 15:3059-3087.
38. Itsykson P., Ilouz N., Turetsky T., Goldstein R.S., Pera M.F., Fishbein I., Segal M., Reubinoff B.E. Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Molecular and Cellular Neuroscience 2005, 30:24-36.
39. Iwasaki H., Mizuno S., Arinobu Y., Ozawa H., Mori Y., Shigematsu H., Takatsu K., Tenen D.G., Akashi K. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes & Development 2006, 20:3010-3021.
40. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of Cellular Biochemistry 1997, 64:295-312.
41. Jang Y.Y., Collector M.I., Baylin S.B., Diehl A.M., Sharkis S.J. Hematopoietic stem cells convert into liver cells within days without fusion. Nature Cell Biology 2004, 6:532-539.
42. Jinnin M., Ihn H., Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Molecular Pharmacology 2006, 69:597-607.
43. Kauffman S.A. Metabolic stability and epigenesis in randomly constructed genetic nets. Journal of Theoretical Biology 1969, 22:437-467.
44. Kawasaki H., Mizuseki K., Nishikawa S., Kaneko S., Kuwana Y., Nakanishi S., Nishikawa S.I., Sasai Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000, 28:31-40.
45. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
46. Kiskinis E., Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. Journal of Clinical Investigation 2010, 120:51-59.
47. Kodama H., Hagiwara H., Sudo H., Amagai Y., Yokota T., Arai N., Kitamura Y. MC3T3-G2/PA6 preadipocytes support in vitro proliferation of hemopoietic stem cells through a mechanism different from that of interleukin 3. Journal of Cellular Physiology 1986, 129:20-26.
48. Kondo M., Scherer D.C., Miyamoto T., King A.G., Akashi K., Sugamura K., Weissman I.L. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 2000, 407:383-386.
49. Kulessa H., Frampton J., Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes & Development 1995, 9:1250-1262.
50. Lamb T.M., Knecht A.K., Smith W.C., Stachel S.E., Economides A.N., Stahl N., Yancopolous G.D., Harland R.M. Neural induction by the secreted polypeptide noggin. Science 1993, 262:713-718.
51. Lamba D.A., Karl M.O., Ware C.B., Reh T.A. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proceedings of the National Academy of Sciences United States of America 2006, 103:12769-12774.
52. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., Martin W., Fornwald J., Lehr R., Harling J., Gaster L., Callahan J.F., Olson B.A. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Molecular Pharmacology 2002, 62:58-64.
53. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., Lin L.Z., Cai C.L., Lu M.M., Reth M., Platoshyn O., Yuan J.X., Evans S., Chien K.R. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
54. Laustriat D., Gide J., Peschanski M. Human pluripotent stem cells in drug discovery and predictive toxicology. Biochemical Society Transactions 2010, 38:1051-1057.
55. Lee J.Y., Tuleuova N., Jones C.N., Ramanculov E., Zern M.A., Revzin A. Directing hepatic differentiation of embryonic stem cells with protein microarray-based co-cultures. Integrative Biology (Cambrige) 2009, 1:460-468.
56. Lengner C.J. iPS cell technology in regenerative medicine. Annals of the New York Academy of Science 2010, 1192:38-44.
57. Li Y., Zhang Q., Yin X., Yang W., Du Y., Hou P., Ge J., Liu C., Zhang W., Zhang X., Wu Y., Li H., Liu K., Wu C., Song Z., Zhao Y., Shi Y., Deng H. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Research 2010, 21:196-204.
58. Lyssiotis C.A., Foreman R.K., Staerk J., Garcia M., Mathur D., Markoulaki S., Hanna J., Lairson L.L., Charette B.D., Bouchez L.C., Bollong M., Kunick C., Brinker A., Cho C.Y., Schultz P.G., Jaenisch R. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:8912-8917.
59. Marchant L., Linker C., Mayor R. Inhibition of mesoderm formation by follistatin. Development Genes and Evolution 1998, 208:157-160.
60. Masip M., Veiga A., Izpisúa Belmonte J.C., Simón C. Reprogramming with defined factors: From induced pluripotency to induced transdifferentiation. Molecular Human Reproduction 2010, 16:856-868.
61. McLean A.B., D'Amour K.A., Jones K.L., Krishnamoorthy M., Kulik M.J., Reynolds D.M., Sheppard A.M., Liu H., Xu Y., Baetge E.E., Dalton S. Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 2007, 25:29-38.
62. Moustakas A., Heldin C.H. The regulation of TGFβ signal transduction. Development 2009, 136:3699-3714.
63. Mummery C.L., van Achterberg T.A., van den Eijnden-van Raaij A.J., van Haaster L., Willemse A., de Laat S.W., Piersma A.H. Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells. Differentiation 1991, 46:51-60.
64. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., Passier R., Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
65. Nishimura K., Sano M., Ohtaka M., Furuta B., Umemura Y., Nakajima Y., Ikehara Y., Kobayashi T., Segawa H., Takayasu S., Sato H., Motomura K., Uchida E., Kanayasu-Toyoda T., Asashima M., Nakauchi H., Yamaguchi T., Nakanishi M. Development of defective and persistent sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. The Journal of Biological Chemistry 2010, 286:4760-4771.
66. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:556-562.
67. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
68. Oldershaw R.A., Baxter M.A., Lowe E.T., Bates N., Grady L.M., Soncin F., Brison D.R., Hardingham T.E., Kimber S.J. Directed differentiation of human embryonic stem cells toward chondrocytes. Nature Biotechnology 2010, 28:1187-1194.
69. Osakada F., Jin Z.B., Hirami Y., Ikeda H., Danjyo T., Watanabe K., Sasai Y., Takahashi M. In vitro differentiation of retinal cells from human pluripotent stem cells by small molecule induction. Journal of Cellular Science 2009, 122:3169-3179.
70. Oshima K., Shin K., Diensthuber M., Peng A.W., Ricci A.J., Heller S. Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells. Cell 2010, 141:704-716.
71. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
72. Peljto M., Dasen J.S., Mazzoni E.O., Jessell T.M., Wichterle H. Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell 2010, 7:355-366.
73. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:12543-12548.
74. Picanço-Castro V., Russo-Carbolante E., Reis L.C., Fraga A.M., de Magalhães D.A., Orellana M.D., Panepucci R.A., Pereira L.V., Covas D.T. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A. Stem Cells and Development 2011, 20:169-180.
75. Rao T.P., Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more. Circulation Research 2010, 106:1798-1806.
76. Rashid S.T., Corbineau S., Hannan N., Marciniak S.J., Miranda E., Alexander G., Huang-Doran I., Griffin J., Ahrlund-Richter L., Skepper J., Semple R., Weber A., Lomas D.A., Vallier L. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. Journal of Clinical Investigation 2010, 120:3127-3136.
77. Rubin L.L. Stem cells and drug discovery: the beginning of a new era?. Cell 2008, 132:549-552.
78. Rubin L.L., de Sauvage F.J. Targeting the Hedgehog pathway in cancer. Nature Reviews Drug Discovery 2006, 5:1026-1033.
79. Schafer B.W., Blakely B.T., Darlington G.J., Blau H.M. Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature 1990, 344:454-458.
80. Shi Y., Desponts C., Do J.T., Hahm H.S., Schöler H.R., Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008, 3:568-574.
81. Shimada H., Hashimoto Y., Nakada A., Shigeno K., Nakamura T. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia. Biochemical and Biophysical Research Communication 2012, 417:659-664.
82. Si-Tayeb K., Noto F.K., Sepac A., Sedlic F., Bosnjak Z.J., Lough J.W., Duncan S.A. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Developmental Biology 2010, 10:81.
83. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., Pedersen R.A. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Developmental Biology 2008, 313:107-117.
84. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., Hoskins E.E., Kalinichenko V.V., Wells S.I., Zorn A.M., Shroyer N.F., Wells J.M. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470:105-109.
85. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
86. Sun N., Longaker M.T., Wu J.C. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle 2010, 9:880-885.
87. Szabo E., Rampalli S., Risueño R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., Levadoux-Martin M., Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
88. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
89. Takahashi T., Lord B., Schulze P.C., Fryer R.M., Sarang S.S., Gullans S.R., Lee R.T. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003, 107:1912-1916.
90. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
91. Tomita S., Li R.K., Weisel R.D., Mickle D.A.G., Kim E.J., Sakai T., Jia Z.Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999, 100:II-247-II-256.
92. Tomita S., Mickle D.A.G., Weisel R.D., Jia Z.Q., Tumiati L.C., Allidina Y., Liu P., Li R.K. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. The Journal of Thoracic and Cardiovascular Surgery 2002, 123:1132-1140.
93. Touboul T., Hannan N.R., Corbineau S., Martinez A., Martinet C., Branchereau S., Mainot S., Strick-Marchand H., Pedersen R., Di Santo J., Weber A., Vallier L. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 2010, 51:1754-1765.
94. Tsai S.Y., Clavel C., Kim S., Ang Y.S., Grisanti L., Lee D.F., Kelley K., Rendl M. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells. Stem Cells 2010, 28:221-228.
95. Turner N., Grose R. Fibroblast growth factor signalling: from development to cancer. Nature Reviews Cancer 2010, 10:116-129.
96. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Südhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
97. Visvader J.E., Elefanty A.G., Strasser A., Adams J.M. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. The EMBO Journal 1992, 11:4557-4564.
98. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
99. Weintraub H., Tapscott S.J., Davis R.L., Thayer M.J., Adam M.A., Lassar A.B., Miller A.D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:5434-5438.
100. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
101. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
102. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hämäläinen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H.K., Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
103. Wright T.J., Mansour S.L. Fgf3 and Fgf10 are required for mouse otic placode induction. Development 2003, 130:3379-3390.
104. Wu X., Ding S., Ding Q., Gray N.S., Schultz P.G. A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. Journal of the American Chemical Society 2002, 124:14520-14521.
105. Wurmser A.E., Nakashima K., Summers R.G., Toni N., D'Amour K.A., Lie D.C., Gage F.H. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004, 430:350-356.
106. Xiong C., Xie C.Q., Zhang L., Zhang J., Xu K., Fu M., Thompson W.E., Yang L.J., Chen Y.E. Derivation of adipocytes from human embryonic stem cells. Stem Cells and Development 2005, 14:671-675.
107. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., Henckaerts E., Bonham K., Abbott G.W., Linden R.M., Field L.J., Keller G.M. Human cardiovascular progenitor cells develop from a KDR+ embryonic stem-cell-derived population. Nature 2008, 453:524-528.
108. Yechoor V., Liu V., Espiritu C., Paul A., Oka K., Kojima H., Chan L. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Developmental Cell 2009, 16:358-373.
109. Yoshida Y., Takahashi K., Okita K., Ichisaka T., Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5:237-241.
110. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
111. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I.I., Thomson J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
112. Zhang Y., Chu Y., Shen W., Dou Z. Effect of 5-azacytidine induction duration on differentiation of human first-trimester fetal mesenchymal stem cells towards cardiomyocyte-like cells. Interactive CardioVascular and Thoracic Surgery 2009, 9:943-946.
113. Zhou H., Ding S. Evolution of induced pluripotent stem cell technology. Current Opinion in Hematology 2010, 17:276-280.
114. Zhou W., Freed C.R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27:2667-2674.
115. Zhou Q., Melton D.A. Extreme makeover: converting one cell into another. Cell Stem Cell 2008, 3:382-388.
116. Zhou Q., Brown J., Kanarek A., Rajagopal J., Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455:627-632.
117. Zhou H., Li W., Zhu S., Joo J.Y., Do J.T., Xiong W., Kim J.B., Zhang K., Schöler H.R., Ding S. Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. Journal of Biological Chemistry 2010, 285:29676-29680.
118. Zhu S., Wurdak H., Wang J., Lyssiotis C.A., Peters E.C., Cho C.Y., Wu X., Schultz P.G. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 2009, 4:416-426.